bit.bio’s Post

View organization page for bit.bio, graphic

19,104 followers

Did you know that in developing therapies for Alzheimer’s disease, researchers face significant challenges because fewer than 10% of findings from preclinical animal models can be translated to humans? Researchers can now access a toolbox of highly consistent, functional and physiologically relevant human ioDisease Model Cells™, powered by opti-ox™, enabling them to develop co-cultures to better represent and model complex multifactorial neurodegenerative disease in vitro. These cells contain disease-relevant mutations for early (APP V717I, APP KM670/671NL, PSEN1 M146L) and late (APOE 4/4 C112R, TREM2 R47H) onset Alzheimer’s and can be paired with genetically matched ioWild Type Cells™. This allows you to make true comparisons and systematically interrogate healthy and diseased states of physiologically relevant cells at a scale suitable for drug target discovery and validation. Learn how to incorporate physiologically relevant and consistent human cells into your research and drug discovery workflows. https://hubs.ly/Q02pZT9P0 #research #DrugDiscovery #AlzheimersDisease #ParkinsonsDisease #science #data #optiox #ioCells #ioDiseaseModelCells

Learn how to incorporate physiologically relevant and consistent human cells into your research and drug discovery workflows!

Learn how to incorporate physiologically relevant and consistent human cells into your research and drug discovery workflows!

bit.bio

To view or add a comment, sign in

Explore topics